Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Glioma

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Glioma in 1 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maccallini, C1
Di Matteo, M1
Gallorini, M1
Montagnani, M1
Graziani, V1
Ammazzalorso, A1
Amoia, P1
De Filippis, B1
Di Silvestre, S1
Fantacuzzi, M1
Giampietro, L1
Potenza, MA1
Re, N1
Pandolfi, A1
Cataldi, A1
Amoroso, R1

Other Studies

1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Glioma

ArticleYear
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma.
    European journal of medicinal chemistry, 2018, May-25, Volume: 152

    Topics: Amidines; Animals; Antineoplastic Agents; Cell Cycle; Cell Proliferation; Cells, Cultured; Dose-Resp

2018